February 3, 2025 — A new study in JAMA Network Open makes one thing very clear. Most people who take GLP-1 medicines for obesity quit within a year. Most who take them for diabetes are less likely to quit. Why are the disparities in GLP-1 medicines for obesity so great in comparison to their use for diabetes? It’s all […]
January 10, 2025 — Let’s talk selfies. For me, they were my reality check. Full-body shots? Forget it. Every milestone photo with my family got run through every beautification filter the App Store could throw at me, but nothing could match the image I wanted to see staring back. That’s when I knew – it was time for a […]
December 6, 2024 — The market for precision nutrition advice is more than six billion dollars today and estimated to double by the end of this decade. Sales of continuous glucose monitoring devices are on their way to $20 billion within three years. But a new study this week in the American Journal of Clinical Nutrition suggests that the […]
November 12, 2024 — For several years now it has been apparent that success in reducing deaths due to cardiovascular disease has slowed or stopped. This is part of the story of declining U.S. life expectancy that headlines often overlook. New research at the upcoming AHA Scientific Sessions tells us rising obesity might explain much of this trend. In […]
October 14, 2024 — Are we on the way to ending weight stigma or is it more stubbornly persistent than we might imagine? We found a clue to the persistence of bias in health professionals in a new commentary published by the Washington Post. From his perch at the Harvard Medical School, Dr. Preston Lee writes: “Like many doctors, […]
October 6, 2024 — Change is in the air at this year’s FNCE – the annual Food and Nutrition Conference and Expo of the Academy of Nutrition and Dietetics. This is the world’s largest meeting of food and nutrition experts, registered dietitians, and nutritionists. But this year, we are seeing a subtle shift in the agenda at FNCE: less […]
September 23, 2024 — FDA is working hard to push drug companies to get more diversity into the clinical trials that are the foundation for bringing new, safe, and effective drugs into the market. In June, the agency issued guidance for diversity action plans to improve the representation of marginalized populations. But unfortunately, it has nothing to say about […]
August 16, 2024 — Is the price for health equity in obesity care too high? Or do policy makers simply not care to make it a priority? Writing in the Washington Post, Reverend Al Sharpton tells us that advances in obesity care bring an appalling failure of health equity into plain view: “Despite rates of obesity among people of […]
July 29, 2024 — When the subject of equitable access to GLP-1s arises, contrasting perspectives of what is equitable become apparent. Last week in the Annals of Internal Medicine, an analysis of prescription data for GLP-1 agonists made two facts about their use very clear. First, their use for obesity is growing much faster than the use for type […]
July 11, 2024 — “Not everything is healthcare,” writes Chris Pope in an essay for the Wall Street Journal, questioning policy advocates who focus on disparity in social determinants of health. In his commentary, he expresses doubt about diverting money from healthcare to other social programs: “Social theories of health have become so popular because they allow states, nonprofit […]
